Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ShiftBio Logo
ShiftBio Growth Score
86
CB Rank
443244
Heat Score
52
ShiftBio is specialized in developing exosome platform technologies to cure rare diseases and cancer.
Founded
obfuscation
Private Seoul, Seoul-t'ukpyolsi, South Korea11-50 shiftbio.net
Biotechnology
Medical
Pharmaceutical
Overview

ShiftBio
Growth Score
86
Heat Score
52

Growth Score86
-1 pts
in past quarter
Heat Score 52
0 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ShiftBio

CB Rank
443244
ShiftBio is specialized in developing exosome platform technologies to cure rare diseases and cancer.
Founded
obfuscation
Private Seoul, Seoul-t'ukpyolsi, South Korea11-50 shiftbio.net
Biotechnology
Medical
Pharmaceutical

Key People

Details

Legal Name ShiftBio Inc
Operating Status Active
Company Type For Profit
Founders  Gi-hoon Nam, In-San Kim, Won-Yong Lee
Contact Email contact@shiftbio.net
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Fusosome
A platform technology that delivers therapeutic proteins, small RNA, and transcription factors into cancer cells by fusing with cancer cell membranes.
SBI-102 (SIRP-NV)
Engineered stem cell-derived nanovesicles targeting CD47 to promote clearance of inflammatory dying cells and reprogram macrophages for regenerative immunotherapy.

Research & Development

ShiftBio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3 Contacts 2

Employee Profiles

News

News and Press

News•Mar 19, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 6, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 9, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 24, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

250
78.57%
 in past month

Active Website Tech Count

21ShiftBio is actively using 21 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  SSL by Default.

Total IP

6The intellectual property of ShiftBio includes 6 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is ShiftBio's headquarters? ShiftBio is located in Seoul, Seoul-t'ukpyolsi, South Korea.Who are ShiftBio's competitors? Alternatives and possible competitors to ShiftBio may include Secretome Therapeutics, Capricor Therapeutics, and  NurExone Biologic.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(be4ac66 1)
|